(9xi,16alpha)-16,17,21-Trihydroxy-9,11-epoxypregna-1,4-diene-3,20-dione(CAS: 215095-77-5)

The compound (9xi,16alpha)-16,17,21-Trihydroxy-9,11-epoxypregna-1,4-diene-3,20-dione (CAS: 215095-77-5) is subject to regulatory guidelines such as GHS classification, REACH regulations, and FDA/EPA requirements for hazardous substances. Specific requirements include proper labeling, storage, and disposal to ensure safety and compliance.

In synthesis, alternatives to (9xi,16alpha)-16,17,21-Trihydroxy-9,11-epoxypregna-1,4-diene-3,20-dione include similar epoxides and related compounds. Common alternatives include 17α-hydroxyprogesterone and 16α-hydroxy-17,21-dihydroxy-9,11-epoxypregna-1,4-diene-3,20-dione, which may offer similar structural and functional properties in certain applications.

The market for (9xi,16alpha)-16,17,21-Trihydroxy-9,11-epoxypregna-1,4-diene-3,20-dione (CAS: 215095-77-5) is growing due to increasing research interest in progestin derivatives. Recent trends indicate a focus on developing new synthetic pathways and exploring its use in reproductive health and hormone-based therapies. The compound's unique epoxide structure is particularly intriguing for drug discovery.

Waste containing (9xi,16alpha)-16,17,21-Trihydroxy-9,11-epoxypregna-1,4-diene-3,20-dione (CAS: 215095-77-5) should be collected in appropriate containers and stored under controlled conditions to prevent degradation. It should be treated as a hazardous material and disposed of through professional waste disposal services that comply with local and international regulations. Proper environmental precautions, such as neutralizing any active components, should be taken to minimize environmental impact.